Price
No data yet.
Social Signal Score
Revenue
$0.00Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Anand Parikh
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 29
- Beta
- -0.31
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 24.51
Financials
Revenue
$0.00Net Income
$-16.01MEBITDA
$-15.98MFree Cash Flow
$-15.67MEPS (diluted)
$-2.84Shares Outstanding (diluted)
5.64M+284.9%Operating Expenses
$18.39MCash & Debt
$186.44MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-21.09M | $-16.72 |
| 2024 | $0.00 | $-30.16M | $-24.01 |
| 2023 | $0.00 | $-34.10M | $-24.40 |
| 2022 | $0.00 | $-48.59M | $-31.65 |
| 2021 | $0.00 | $-36.79M | $-26.56 |
| 2020 | $0.00 | $-20.10M | $-13.21 |
| 2019 | $0.00 | $-16.74M | $-14.01 |
| 2018 | $0.00 | $-13.04M | $-11.49 |
Valuation
FTHhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newszacks.com·5h ago·Neutral
Wall Street Analysts Predict a 72.22% Upside in Faeth Therapeutics, Inc. (FTH): Here's What You Should Know The mean of analysts' price targets for Faeth Therapeutics, Inc. (FTH) points to a 72.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
View source ↗
Earnings
Fri, Nov 13(in 3 months)
Consensus estimate $-0.66 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$-2.84 vs $-2.64miss
- Fri, May 15$-131.45 vs $-0.62miss
- Mon, Mar 30$-3.74 vs $-4.81beat
- Fri, Nov 14$-3.62 vs $-4.11beat
- Tue, Aug 5$-3.91 vs $-6.20beat
- Tue, May 6$-5.40 vs $-4.20miss
Estimates and results for FTH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by FTH officers and directors.
- Bought
- $2.5m
- Sold
- $1.7m
49 trades
27 trades
- Stephenson Brian Cbought
- Stephenson Brian Cbought
- Stephenson Brian Cbought
- Stephenson Brian Cbought
- Stephenson Brian Cbought
- Stephenson Brian Cbought
- Stephenson Brian Cbought
- Stephenson Brian Cbought
24 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.